Kymera Therapeutics to Participate in Investor Conferences
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a leader in discovering and developing targeted protein degradation medicines, is set to engage in several significant investor events. This participation aims to showcase their advancements in biotechnology and increase investor awareness.
Scheduled Investor Events
The company has announced its attendance at three notable investor conferences:
1. Piper Sandler Annual Healthcare Conference
Kymera will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2. This event, occurring at 2:30 p.m. ET in New York, offers a platform for discussing the company's recent developments and future directions.
2. Citi 2025 Global Healthcare Conference
Following this, they will present at the Citi 2025 Global Healthcare Conference, scheduled for December 3 at 11:15 a.m. ET in Miami, Florida. The event is expected to gather key investors and industry leaders.
3. Evercore Annual Healthcare Conference
Lastly, on December 4 at 8:45 a.m. ET, Kymera will partake in the Evercore 8th Annual Healthcare Conference located in Coral Gables, Florida. This conference will provide additional opportunities to engage with investors.
Live Webcasts Available
For those unable to attend, live webcasts of these presentations will be available in the Investors section of Kymera's official website. After the events, recorded sessions will also be accessible for later viewing.
About Kymera Therapeutics
Kymera Therapeutics stands at the forefront of clinical-stage biotechnology, pioneering innovative treatments through targeted protein degradation technology. Their mission is to develop oral small-molecule degraders that provide highly effective therapies for immunological diseases, addressing areas often overlooked by traditional therapeutics.
Established in 2016, Kymera Therapeutics has made significant strides in the biopharmaceutical landscape. The company is recognized as one of Boston's top workplaces, further enhancing its reputation within the industry. Their ongoing commitment is to expand an industry-leading pipeline that aims to significantly improve patient outcomes through new therapeutic approaches.
Investor and Media Contact Information
For additional inquiries, Justine Koenigsberg, the Vice President of Investor Relations, is available to assist. Interested parties can reach out via:
Email: investors@kymeratx.com
Email: media@kymeratx.com
Phone: 857-285-5300
Frequently Asked Questions
What is Kymera Therapeutics known for?
Kymera Therapeutics is noted for its innovative approach to targeted protein degradation, developing therapies for various diseases.
When will Kymera participate in the upcoming conferences?
Kymera will attend the Piper Sandler Conference on December 2, the Citi Global Healthcare Conference on December 3, and the Evercore Conference on December 4.
Are webcasts of the events available?
Yes, live webcasts will be available on the company's website, along with recordings for later viewing.
How can I contact Kymera Therapeutics for investor inquiries?
Contact Justine Koenigsberg via email at investors@kymeratx.com or by phone at 857-285-5300 for investor-related questions.
What is the goal of Kymera Therapeutics in these conferences?
The goal is to engage with investors and showcase their advancements in biotech, enhancing awareness and interest in their projects and pipeline.
